Figure 2.
Kaplan–Meier estimates of overall survival.
Notes: Panel shows the results of the analysis of efficacy of immunotherapy compared with control (median survival in immunotherapy, 29.70 months; in control, 19.90 months; P=0.036).
Kaplan–Meier estimates of overall survival.
Notes: Panel shows the results of the analysis of efficacy of immunotherapy compared with control (median survival in immunotherapy, 29.70 months; in control, 19.90 months; P=0.036).